In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1731 News Items found
Q&A
MSK hematological oncologist Lindsey Roeker
Meet Chronic Lymphocytic Leukemia Expert Lindsey Roeker

Meet hematologic oncologist Lindsey Roeker and learn why people who have been diagnosed with chronic lymphocytic leukemia should come to MSK.
Dr. John Chodera in his lab
Shooting for the Moon: How the Drive To Tackle COVID-19 Will Speed Up Cancer Drug Discovery

During the pandemic, Dr. John Chodera’s lab shifted gears to help find new drugs against COVID-19. Learn how lessons from the effort are already aiding in the search for new cancer drugs.
MSK nurse scientists Ann Marie Mazzella-Ebstein, Margaret Barton-Burke, and Kristen Fessele
MSK Nurse Scientists: Driven by Compassion — and Data

Like all researchers, nurse scientists design studies, accumulate data, and publish their findings. Their concentration in nursing means that they’re focused on patient needs, perspectives, and outcomes. Whereas a medical doctor might study how a drug is working, a nurse scientist may take a more holistic view of how a treatment affects a patient’s and their family’s quality of life.
three tobacco hornworm caterpillars held in a scientist's hand
Move Over, Mice: Caterpillars Could Replace Some Mammals in the Study of Human Disease

How scientists are working to develop nonmammalian alternatives that could reduce the number of rodents used in biomedical research.
Postdoctoral researcher Yanan Ma, PhD
Go Fish: Why MSK Researchers Use Zebrafish To Study a Cancer-Linked Inflammation Pathway

A study led by postdoctoral researcher Yanan Ma from the lab of cell biologist Philipp Niethammer shows why diversity also matters in model animal research.
Boris Mueller, MD, Director, Radiation Oncology at MSK Bergen is seen standing in a hallway.
Breast Cancer and Tattoo-Less Radiation at MSK

Learn how people with early stage breast cancer can receive radiation therapy without the need for tattoos at Memorial Sloan Kettering Cancer Center.
Attendees of the fifth annual MSK-CTONG Symposium
Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Urge International Harmonization to Accelerate Cancer Drug Approvals at Annual Event

Global regulatory harmonization of clinical trials provides significant opportunity to accelerate access to cancer treatments to benefit all of humanity. This was the theme of the fifth annual MSK-CTONG Symposium, hosted online for a global audience of 20,000 from Guangzhou, China and New York on December 2, 2022.
detail shot of laboratory slides
MSK Research Highlights, December 23, 2022

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute explores ways to limit heart damage from chemotherapy and radiation; examines genomic differences between primary and metastatic tumors in bladder cancer; aims to understand the safety of check point inhibitor therapy for patients who are obese; and investigates a potential therapeutic approach against acute myeloid leukemia.
Feature
x-ray of bladder with large tumor
Bladder Preservation in Muscle-Invasive Bladder Cancer Based on DDR Genetic Mutations

MSK researchers are investigating a new way that people with bladder cancer can avoid bladder removal.
In the Lab
Dmitriy Zamarin and Sohrab Shah
MSK Team Focuses on Resistance to Immunotherapy in Ovarian Cancer

A collaborative team from MSK has uncovered important new findings that explain why ovarian cancer does not respond to immunotherapy.